Skip to main content
Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology 6/2005

01.06.2005 | Laboratory Investigation

Inhibition of human lens epithelial B-3 cell proliferation by adenovirus-mediated transfer of antisense c-myc construct

verfasst von: Jie Sun, Lixin Xie, Yao Wang, Ting Liu

Erschienen in: Graefe's Archive for Clinical and Experimental Ophthalmology | Ausgabe 6/2005

Einloggen, um Zugang zu erhalten

Abstract

Purpose

To investigate the effects of adenovirus-mediated transfer of antisense c-myc construct on human lens epithelial B-3 (HLE B-3) cell proliferation, apoptosis and cell cycle.

Methods

HLE B-3 cell cultures were transduced with replication-defective adenovirus bearing either a nuclear-targeted β-galactosidase (Ad-lacZ) or an antisense c-myc construct (Ad-AS-myc). The presence of β-galactosidase activity in the transduced cultures was detected by immunohistochemical X-Gal staining, while c-myc mRNA and protein expression levels were evaluated by RT-PCR and Western blot analysis. HLE B-3 cell proliferation within 96 h after the transduction was analyzed by cell counting and MTT colorimetric assay. Apoptosis and cell cycle of the HLE-B3 cells were examined by flow-cytometric analysis.

Results

The mean transduction efficiency was 80% for HLE B-3 cells. Downregulation of c-myc mRNA and protein expression was noticed at 48, 96 and 144 h after the transduction with Ad-AS-myc. Cytostatic effects of Ad-AS-myc in HLE B-3 cells were obvious within 96 h after the transduction. An increased incidence of apoptosis and G1-phase arrest was identified in the Ad-AS-myc-transduced HLE B-3 cells.

Conclusions

HLE B-3 cells were successfully transduced with adenovirus-mediated antisense c-myc construct. Ad-AS-myc transduction could significantly inhibit cell proliferation and induce cell apoptosis and G1-phase arrest in HLE B-3 cells. It may provide a novel approach for prevention of posterior capsular opacification.
Literatur
1.
Zurück zum Zitat Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF, Tsai JC, Castaneda VE, Hoggatt JP, Kostick AM (1992) Posterior capsule opacification. Surv Ophthalmol 37:73–116CrossRefPubMed Apple DJ, Solomon KD, Tetz MR, Assia EI, Holland EY, Legler UF, Tsai JC, Castaneda VE, Hoggatt JP, Kostick AM (1992) Posterior capsule opacification. Surv Ophthalmol 37:73–116CrossRefPubMed
2.
Zurück zum Zitat Capeans C, Pineiro A, Dominguez F, Loidi L, Buceta M, Carneiro C, Garcia-Caballero T, Sanchez-Salorio M (1998) A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation. Exp Eye Res 66:581–589 Capeans C, Pineiro A, Dominguez F, Loidi L, Buceta M, Carneiro C, Garcia-Caballero T, Sanchez-Salorio M (1998) A c-myc antisense oligonucleotide inhibits human retinal pigment epithelial cell proliferation. Exp Eye Res 66:581–589
3.
Zurück zum Zitat Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL (2002) Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens. Cancer Res 62:3126–3131 Carroll JS, Swarbrick A, Musgrove EA, Sutherland RL (2002) Mechanisms of growth arrest by c-myc antisense oligonucleotides in MCF-7 breast cancer cells: implications for the antiproliferative effects of antiestrogens. Cancer Res 62:3126–3131
4.
Zurück zum Zitat Chen JP, Lin C, Xu CP, Zhang XY, Fu M, Deng YP, Wei Y, Wu M (2001) Molecular therapy with recombinant antisense c-myc adenovirus for human gastric carcinoma cells in vitro and in vivo. J Gastroenterol Hepatol 16:22–28 Chen JP, Lin C, Xu CP, Zhang XY, Fu M, Deng YP, Wei Y, Wu M (2001) Molecular therapy with recombinant antisense c-myc adenovirus for human gastric carcinoma cells in vitro and in vivo. J Gastroenterol Hepatol 16:22–28
5.
Zurück zum Zitat De Nigris F, Sica V, Herrmann J, Condorelli G, Chade AR, Tajana G, Lerman A, Lerman LO, Napoli C (2003) c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases. Cell Cycle 2:325–328 De Nigris F, Sica V, Herrmann J, Condorelli G, Chade AR, Tajana G, Lerman A, Lerman LO, Napoli C (2003) c-Myc oncoprotein: cell cycle-related events and new therapeutic challenges in cancer and cardiovascular diseases. Cell Cycle 2:325–328
6.
Zurück zum Zitat Heufelder AE, Bahn RS (1995) Modulation of cellular functions in retroorbital fibroblasts using antisense oligonucleotides targeting the c-myc protooncogene. Invest Ophthalmol Vis Sci 36:1420–1432 Heufelder AE, Bahn RS (1995) Modulation of cellular functions in retroorbital fibroblasts using antisense oligonucleotides targeting the c-myc protooncogene. Invest Ophthalmol Vis Sci 36:1420–1432
7.
Zurück zum Zitat Hodge WG (1992) Posterior capsule opacification after cataract surgery. Ophthalmology 105:943–944 Hodge WG (1992) Posterior capsule opacification after cataract surgery. Ophthalmology 105:943–944
8.
Zurück zum Zitat Ismail MM, Alio JL, Ruiz Moreno JM (1996) Prevention of secondary cataract by antimitotic drugs: experimental study. Ophthalmic Res 28:64–69 Ismail MM, Alio JL, Ruiz Moreno JM (1996) Prevention of secondary cataract by antimitotic drugs: experimental study. Ophthalmic Res 28:64–69
9.
Zurück zum Zitat Iversen PL, Arora V, Acker AJ, Mason DH, Devi GR (2003) Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans. Clin Cancer Res 9:2510–2519 Iversen PL, Arora V, Acker AJ, Mason DH, Devi GR (2003) Efficacy of antisense morpholino oligomer targeted to c-myc in prostate cancer xenograft murine model and a Phase I safety study in humans. Clin Cancer Res 9:2510–2519
10.
Zurück zum Zitat Legler UF, Apple DJ, Assia EI, Bluestein EC, Castaneda VE, Mowbray SL (1993) Inhibition of posterior capsule opacification: the effect of colchicine in a sustained drug delivery system. J Cataract Refract Surg 19:462–470 Legler UF, Apple DJ, Assia EI, Bluestein EC, Castaneda VE, Mowbray SL (1993) Inhibition of posterior capsule opacification: the effect of colchicine in a sustained drug delivery system. J Cataract Refract Surg 19:462–470
11.
Zurück zum Zitat Mirza MA, Weber J (1979) Uncoating of adenovirus type 2. J Virol 30:462–471 Mirza MA, Weber J (1979) Uncoating of adenovirus type 2. J Virol 30:462–471
12.
Zurück zum Zitat Nishi O (1986) Incidence of posterior capsule opacification in eyes with and without posterior chamber intraocular lenses. J Cataract Refract Surg 12:519–522 Nishi O (1986) Incidence of posterior capsule opacification in eyes with and without posterior chamber intraocular lenses. J Cataract Refract Surg 12:519–522
13.
Zurück zum Zitat Pastorino F, Brignole C, Marimpietri D, Pagnan G, Morando A, Ribatti D, Semple SC, Gambini C, Allen TM, Ponzoni M (2003) Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Clin Cancer Res 9:4595–4605 Pastorino F, Brignole C, Marimpietri D, Pagnan G, Morando A, Ribatti D, Semple SC, Gambini C, Allen TM, Ponzoni M (2003) Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models. Clin Cancer Res 9:4595–4605
14.
Zurück zum Zitat Pelengaris S, Khan M (2003) The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin Ther Targets 7:623–642 Pelengaris S, Khan M (2003) The c-MYC oncoprotein as a treatment target in cancer and other disorders of cell growth. Expert Opin Ther Targets 7:623–642
15.
Zurück zum Zitat Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL (1998) c-myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol 18:4499–4508 Prall OW, Rogan EM, Musgrove EA, Watts CK, Sutherland RL (1998) c-myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry. Mol Cell Biol 18:4499–4508
16.
Zurück zum Zitat Simile MM, De Miglio MR, Muroni MR, Frau M, Asara G, Serra S, Muntoni MD, Seddaiu MA, Daino L, Feo F, Pascale RM (2004) Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis 25:333–341 Simile MM, De Miglio MR, Muroni MR, Frau M, Asara G, Serra S, Muntoni MD, Seddaiu MA, Daino L, Feo F, Pascale RM (2004) Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis 25:333–341
17.
Zurück zum Zitat Smith JB, Wickstrom E (1998) Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model. J Natl Cancer Inst 90:1146–1154 Smith JB, Wickstrom E (1998) Antisense c-myc and immunostimulatory oligonucleotide inhibition of tumorigenesis in a murine B-cell lymphoma transplant model. J Natl Cancer Inst 90:1146–1154
18.
Zurück zum Zitat Wen Y, Shu S, Unakar NJ, Bekhor I (1992) Expression of c-myc protooncogene in rat lens cells during development, maturation and reversal of galactose cataracts. Mol Cell Biochem 112:73–79 Wen Y, Shu S, Unakar NJ, Bekhor I (1992) Expression of c-myc protooncogene in rat lens cells during development, maturation and reversal of galactose cataracts. Mol Cell Biochem 112:73–79
Metadaten
Titel
Inhibition of human lens epithelial B-3 cell proliferation by adenovirus-mediated transfer of antisense c-myc construct
verfasst von
Jie Sun
Lixin Xie
Yao Wang
Ting Liu
Publikationsdatum
01.06.2005
Erschienen in
Graefe's Archive for Clinical and Experimental Ophthalmology / Ausgabe 6/2005
Print ISSN: 0721-832X
Elektronische ISSN: 1435-702X
DOI
https://doi.org/10.1007/s00417-004-1095-4

Weitere Artikel der Ausgabe 6/2005

Graefe's Archive for Clinical and Experimental Ophthalmology 6/2005 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

Ophthalmika in der Schwangerschaft

Die Verwendung von Ophthalmika in der Schwangerschaft und Stillzeit stellt immer eine Off-label-Anwendung dar. Ein Einsatz von Arzneimitteln muss daher besonders sorgfältig auf sein Risiko-Nutzen-Verhältnis bewertet werden. In der vorliegenden …

Operative Therapie und Keimnachweis bei endogener Endophthalmitis

Vitrektomie Originalie

Die endogene Endophthalmitis ist eine hämatogen fortgeleitete, bakterielle oder fungale Infektion, die über choroidale oder retinale Gefäße in den Augapfel eingeschwemmt wird [ 1 – 3 ]. Von dort infiltrieren die Keime in die Netzhaut, den …

Bakterielle endogene Endophthalmitis

Vitrektomie Leitthema

Eine endogene Endophthalmitis stellt einen ophthalmologischen Notfall dar, der umgehender Diagnostik und Therapie bedarf. Es sollte mit geeigneten Methoden, wie beispielsweise dem Freiburger Endophthalmitis-Set, ein Keimnachweis erfolgen. Bei der …

So erreichen Sie eine bestmögliche Wundheilung der Kornea

Die bestmögliche Wundheilung der Kornea, insbesondere ohne die Ausbildung von lichtstreuenden Narben, ist oberstes Gebot, um einer dauerhaften Schädigung der Hornhaut frühzeitig entgegenzuwirken und die Funktion des Auges zu erhalten.   

Update Augenheilkunde

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.